Zytorvi Wins Regulatory Nod For Cancer Treatments

India's drug regulator has approved Dr Reddy's Zytorvi for treating advanced oesophageal cancer alongside chemotherapy. The immunotherapy drug offers another option for eligible adults. Clinical trials showed a 42% reduction in the risk of disease progression or death compared with chemotherapy alone, marking a major treatment advance.